Stocks Health care DCTH
NASDAQ · Health careDelcath Systems, Inc. (DCTH)
Delcath Systems, Inc. brought in $110M of revenue over the twelve months to September 30, 2026, up 38.1% from a year earlier. Net income was $6.7M, a net margin of 6.1%. Operating cash flow minus capital spending left $21M of free cash flow in fiscal 2025. At September 30, 2026 it held $55.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 9, 2026.
Key facts about Delcath Systems, Inc.
- Net worth
- Delcath Systems, Inc. has a market value (market cap) of $703.3M at the latest share price, and shareholders' equity of $133.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $85.2M (+129.1% year on year), with net income of $2.7M. Over the 12 months to September 30, 2026: revenue $110M, net income $6.7M.
- Cash flow
- In fiscal 2025 operations brought in $22.5M of cash; after $1.5M of capital spending, free cash flow was $21M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 9, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Delcath Systems, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Delcath Systems, Inc. does
Delcath Systems, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker DCTH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $85.2M | $2.7M | $0.07 | $21M |
| 2024 | $37.2M | -$26.4M | -$0.93 | -$19.2M |
| 2023 | $2.1M | -$47.7M | -$2.94 | -$31.3M |
| 2022 | $2.7M | -$36.5M | -$4.12 | -$25.2M |
| 2021 | $3.6M | -$25.6M | -$3.59 | -$22.7M |
| 2020 | n/a | -$24.2M | -$8.35 | -$23.7M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where DCTH ranks in Health care
Latest SEC filings
What Delcath Systems, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 71% to $35.1M versus the same quarter last year; diluted EPS $0.17 versus $0.02.
- November 9, 2026
- October 27, 2026Passive stake (5% or more) SCHEDULE 13G
- October 19, 2026Activist stake changed SCHEDULE 13D/A
- August 14, 2026
- August 14, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 21% to $29.1M versus the same quarter last year; diluted EPS $0.07 versus $0.07.
- August 6, 2026
- July 28, 2026Passive stake (5% or more) SCHEDULE 13G
- May 14, 2026
What is DCTH worth? A DCF from its reported cash flow
Insider trades
What the people running Delcath Systems, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 13, 2026 | Rosalind Advisors, Inc.Director | Exercised optionsindirect | 3,627 | - |
| October 13, 2026 | Rosalind Advisors, Inc.Director | Other changeindirect | 27,502 | - |
| March 6, 2026 | Pennell SandraChief Financial Officer | Bought | 5,533 | $50K |
| March 2, 2026 | Michel Gerard JCHIEF EXECUTIVE OFFICER, Director | Bought | 11,200 | $100.3K |
| November 21, 2025 | Sylvester John RichardDirector | Bought | 4,386 | $39K |
| November 11, 2025 | Michel Gerard JCHIEF EXECUTIVE OFFICER, Director | Bought | 11,500 | $98K |
Who owns DCTH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Rosalind Advisors, Inc.13D, may seek influence with 4 related filers | 9.9% | February 10, 2026 |
| BlackRock Portfolio Management LLC13G, passive | 6.3% | October 27, 2026 |
| Daniel Kaufman13G, passive | 5.08% | March 20, 2026 |
Largest institutional holders
Insiders
4 insiders reported holding 3,823,581 shares in total, about $77.5M at the last price.
| Holder | Shares |
|---|---|
| Rosalind Advisors, Inc.Director | 3,389,5933,389,593 held indirectly |
| Michel Gerard JCHIEF EXECUTIVE OFFICER, Director | 342,034 |
| Pennell SandraChief Financial Officer | 77,018 |
| Sylvester John RichardDirector | 14,936 |
Questions about DCTH
What does Delcath Systems, Inc. do?
Delcath Systems, Inc. is a company in the Health care sector, listed on NASDAQ as DCTH. Its shares trade on NASDAQ under the ticker DCTH.
What is Delcath Systems, Inc.'s net worth?
Delcath Systems, Inc. has a market value (market cap) of $703.3M at the latest share price, and shareholders' equity of $133.5M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Delcath Systems, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $6.7M on revenue of $110M, a net margin of 6.1%.
How much revenue does Delcath Systems, Inc. make?
Over the twelve months to September 30, 2026 Delcath Systems, Inc. reported revenue of $110M. That is 38.1% more than a year earlier.
When did Delcath Systems, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 9, 2026. It covers the period to September 30, 2026.
When is Delcath Systems, Inc.'s next earnings report?
Delcath Systems, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare DCTH with
Follow DCTH
Get an email when Delcath Systems, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Delcath Systems, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.